Vai offline con l'app Player FM !
Episode 22. Management of Low-Risk MDS
Manage episode 363911680 series 3369804
In this episode, we take a deep dive into low-risk MDS management. We have the privilege of being joined by the esteemed Dr. Mikkael Sekeres. We also explore his invaluable insights gained from his time at FDA ODAC and his latest literary endeavor, "Drugs and the FDA".
Here are the key studies discussed:
1. ASH choosing wisely:
https://www.hematology.org/education/clinicians/guidelines-and-quality-care/choosing-wisely
2. International Consensus Classification (ICC):
https://pubmed.ncbi.nlm.nih.gov/35767897/
3. WHO classification 2022:
https://pubmed.ncbi.nlm.nih.gov/35732829/
4. IPSS-M:
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200008
5. Romiplostim in MDS:
https://pubmed.ncbi.nlm.nih.gov/29396092/
6. Low-dose decitabine vs. low-dose azacItidine in lower-risk MDS:
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200034
7. Luspatercept in MDS:
https://www.nejm.org/doi/full/10.1056/nejmoa1908892
8. Lenalidomide in MDS:
https://ascopubs.org/doi/10.1200/JCO.2015.66.0118
https://pubmed.ncbi.nlm.nih.gov/21753188/
9.Iron chelation therapy in MDS:
https://pubmed.ncbi.nlm.nih.gov/32203980/
54 episodi
Manage episode 363911680 series 3369804
In this episode, we take a deep dive into low-risk MDS management. We have the privilege of being joined by the esteemed Dr. Mikkael Sekeres. We also explore his invaluable insights gained from his time at FDA ODAC and his latest literary endeavor, "Drugs and the FDA".
Here are the key studies discussed:
1. ASH choosing wisely:
https://www.hematology.org/education/clinicians/guidelines-and-quality-care/choosing-wisely
2. International Consensus Classification (ICC):
https://pubmed.ncbi.nlm.nih.gov/35767897/
3. WHO classification 2022:
https://pubmed.ncbi.nlm.nih.gov/35732829/
4. IPSS-M:
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200008
5. Romiplostim in MDS:
https://pubmed.ncbi.nlm.nih.gov/29396092/
6. Low-dose decitabine vs. low-dose azacItidine in lower-risk MDS:
https://evidence.nejm.org/doi/full/10.1056/EVIDoa2200034
7. Luspatercept in MDS:
https://www.nejm.org/doi/full/10.1056/nejmoa1908892
8. Lenalidomide in MDS:
https://ascopubs.org/doi/10.1200/JCO.2015.66.0118
https://pubmed.ncbi.nlm.nih.gov/21753188/
9.Iron chelation therapy in MDS:
https://pubmed.ncbi.nlm.nih.gov/32203980/
54 episodi
Tutti gli episodi
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.